Health Condition 1: J00-J99- Diseases of the respiratory system
Conditions
Interventions
Intervention1: High-Frequency Chest Wall Oscillation (HFCWO): • High-Frequency Chest Wall Oscillation (HFCWO) sessions will be conducted thrice weekly for a duration of 4 weeks.
• Each session will la
Sponsors
NO
Eligibility
Inclusion criteria
Inclusion criteria: 1.Confirmed COPD Diagnosis: Participants must have a confirmed diagnosis of COPD. 2.Specific Age Range: 18 Years to 45 Years. 3.Stable Disease State: Participants should be in a stable COPD state without recent exacerbations. 4.Informed Consent: Ability to provide informed consent for voluntary participation. 5.Adherence to Treatment Protocols: Willingness to comply with HFCWO and CPT treatment protocols. 6.Ability to Use HFCWO Device or Receive CPT: Physical capability to use HFCWO or receive CPT. 7.Stable Medication Regimen: On a stable COPD medication regimen with documented changes. 8.Compliance with Study Visits: Commitment to attending scheduled visits and assessments. 9.No Contraindications: Absence of contraindications to HFCWO or CPT. 10.Language Proficiency: Proficient in the language(s) used for study communication and assessments.
Exclusion criteria
Exclusion criteria: 1.Unstable Medical Conditions: Exclusion of individuals with acute medical conditions other than COPD. 2.Severe Cognitive Impairment: Exclusion of those with severe cognitive impairment affecting decision-making. 3.Recent Exacerbations: Exclusion of participants with recent COPD exacerbations. 4.Severe Respiratory Distress: Exclusion of individuals in severe respiratory distress or requiring urgent medical intervention. 5.Contraindications to HFCWO or CPT: Exclusion of participants with contraindications to HFCWO or CPT. 6.Inability to Use HFCWO or Receive CPT: Exclusion of individuals physically unable to use HFCWO or receive CPT. 7.Pregnancy: Exclusion of pregnant individuals for safety reasons. 8.Non-compliance with Study Requirements: Exclusion of those unwilling or unable to comply with study protocols.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in forced expiratory volume in one second (FEV1)Timepoint: baseline, 4 weeks & 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency and duration of hospitalizations due to COPD exacerbations. Change in peak expiratory flow rate (PEFR) or other measures of lung function. Adverse events or complications related to treatment. Patient adherence to treatment regimen. Change in respiratory muscle strength.Timepoint: 2 WEEKS,4 WEEKS | — |
Countries
India
Contacts
Public ContactPankaj Singh
Galgotias University
Outcome results
None listed